Mirion Technologies, Inc.

Listed Company

MIRCIK 0001809987NYSELarge AcceleratedMeasuring & Controlling Devices, NecFY ends Dec 31

Period

FY 2025

Revenue

$925.40M

Net Income

$28.80M

Total Assets

$3.59B

Equity

$1.87B

Shares Out

18.75M

Op. Cash Flow

$143.30M

Business

Mirion Technologies, Inc. supplies radiation detection, measurement, analysis and monitoring products, software and services that support safe use of ionizing radiation in industry, research and healthcare. Products include detectors, monitoring and laboratory instruments, imaging and waste management systems, QA tools for radiotherapy and nuclear medicine, dosimetry platforms and software. The company has two segments: Nuclear & Safety for nuclear, research, industrial and defense markets, and Medical for cancer care, diagnostics and dosimetry. Sales are direct and through distributors across North America, Europe and Asia.

Summary from filing dated 2025-02-26

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Total revenues	925	861	801	718	—
Total cost of revenues	487	461	445	408	—
Gross profit	439	400	356	310	—
Selling, general and administrative	348	341	340	362	—
Research and development	39	35	32	30	—
(Gain) loss on disposal of business	0	−1	7	0	—
Total operating expenses	387	375	378	608	—
Income (loss) from operations	52	25	−22	−298	—
Interest expense	42	58	62	—	—
Interest income	−12	−7	−5	−600,000	—
Loss on debt extinguishment	6	0	3	0	—
Foreign currency (gain) loss, net	−17	2	−300,000	5	—
Increase in fair value of warrant liabilities	0	5	25	−38	—
Other expense (income), net	300,000	−100,000	−800,000	−400,000	—
Income (loss) before income taxes	33	−34	−105	−307	—
Income tax expense (benefit)	3	3	−7	−18	—
Net income (loss)	30	−37	−99	−288	−158
Income (loss) attributable to noncontrolling interests	1	−500,000	−2	−12	—
Net income (loss) attributable to Mirion Technologies, Inc.	29	−36	−97	−277	—
Basic (in dollars per share)	0.13	−0.18	−0.49	−1.53	—
Diluted (in dollars per share)	0.11	−0.18	−0.49	−1.53	—
Basic (in shares)	230	205	196	181	—
Diluted (in shares)	261	205	196	181	—

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2022 2022-06-30
Cash and cash equivalents	412	175	129	74	—
Accounts receivable, net of allowance for doubtful accounts	182	178	172	171	—
Costs in excess of billings on uncompleted contracts	94	67	49	—	—
Inventories	153	133	144	143	—
Prepaid expenses and other current assets	53	42	44	34	—
Total current assets	894	595	539	481	—
Property, plant, and equipment, net	155	146	135	124	89
Operating lease right-of-use assets	32	30	33	40	—
Goodwill	1,872	1,426	1,448	1,418	—
Intangible assets, net	606	412	539	650	—
Other assets	29	27	25	24	—
Total assets	3,588	2,636	2,719	2,739	—
Accounts payable	57	57	59	68	—
Deferred contract revenue	112	97	103	—	—
Debt, current	2	1	—	—	—
Operating lease liability, current	8	6	7	9	—
Derivative liabilities, current	21	3	—	—	—
Accrued expenses and other current liabilities	116	99	96	80	—
Total current liabilities	316	263	266	244	—
Debt, non-current	443	685	—	—	—
Convertible debt	755	0	—	—	—
Operating lease liability, non-current	27	27	28	34	—
Deferred income taxes, non-current	70	61	84	—	—
Other liabilities	61	40	51	—	—
Total liabilities	1,671	1,077	1,169	1,272	—
Commitments and contingencies (Note 11)	—	—	—	—	—
Treasury stock, at cost; 3,492,619 shares at December 31, 2025, and 288,013 shares at December 31, 2024	−58	−3	−1	0	—
Additional paid-in capital	2,490	2,143	2,057	1,882	—
Accumulated deficit	−513	−542	−505	−409	—
Accumulated other comprehensive loss	−53	−93	−65	−76	—
Mirion Technologies, Inc. stockholders equity	1,866	1,506	1,485	1,398	—
Noncontrolling interests	51	54	66	69	—
Total stockholders equity	1,917	1,559	1,550	1,467	—
Total liabilities and stockholders equity	3,588	2,636	2,719	2,739	—
Treasury stock, common (in shares)	3	288,013	149,076	0	—

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-06-30
Depreciation and amortization expense	138	150	163	175	84
Stock-based compensation expense	15	16	22	32	0
Amortization of debt issuance costs	4	3	3	4	3
Provision for doubtful accounts	3	3	2	300,000	2
Inventory obsolescence write down	2	5	2	900,000	700,000
Change in deferred income taxes	−22	−24	−31	−37	−17
Loss on disposal of property, plant and equipment and badges	600,000	500,000	600,000	3	−100,000
(Gain) loss on foreign currency transactions	−17	2	−300,000	5	13
(Gain) loss on disposal of business	0	−1	7	0	0
Other	1	2	−600,000	4	1
Accounts receivable	15	−12	−5	−15	−4
Costs in excess of billings on uncompleted contracts	−8	−24	2	−5	—
Inventories	3	1	−500,000	−35	−4
Deferred cost of revenue	−100,000	300,000	700,000	−800,000	7
Prepaid expenses and other current assets	−9	−3	−14	−2	−10
Accounts payable	−11	−2	−10	5	3
Accrued expenses and other current liabilities	−300,000	11	3	6	−2
Deferred contract revenue	−900,000	−1	24	7	−3
Other assets	−1	900,000	300,000	5	500,000
Other liabilities	−3	500,000	−700,000	−3	8
Net cash provided by operating activities	143	99	95	39	54
Acquisitions of businesses, net of cash and cash equivalents acquired	−662	−1	−31	−7	−290
Proceeds from disposal of property, plant, and equipment and badges	1	0	0	800,000	0
Purchases of property, plant, and equipment and badges	−36	−49	−37	−34	−23
Proceeds from net investment hedge derivative contracts	3	4	4	500,000	0
Proceeds from business disposal	0	3	1	0	0
Other investing	0	0	−1	0	0
Net cash used in investing activities	−695	−44	−65	−40	−313
Issuances of common stock	425	0	150	0	0
Common stock issuance costs	−15	0	−300,000	0	0
Stock repurchased to satisfy tax withholding for vesting restricted stock units	−6	−2	−1	—	—
Purchases of stock for treasury	−50	0	0	0	0
Proceeds from issuance of convertible senior notes, net of bank costs	755	0	0	—	—
Third-party issuance costs for convertible senior notes	−1	0	0	—	—
Purchase of capped calls related to convertible senior notes	−83	0	0	—	—
Term loan principal repayments	−245	0	−127	−7	−15
Financing costs	−4	−1	0	0	0
Proceeds from cash flow hedge derivative contracts	700,000	1	600,000	0	0
Other financing	−1	−1	600,000	−400,000	0
Net cash provided by (used in) financing activities	776	−3	23	−7	239
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	15	−7	2	−3	—
Net increase in cash, cash equivalents, and restricted cash	240	45	56	−10	−18

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro